Skip to content

Lucid Diagnostics LUCD Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Operating margin-959.6%+95.2pp-1,054.8%+36.4pp-1,091.3%+8.3pp-1,099.5%+44.7pp-1,144.2%-84.5pp
Net margin-876.7%+356pp-1,232.7%-21.4pp-1,211.3%+56.1pp-1,267.4%+214pp-1,481.5%-434pp
EBITDA margin-942.6%+93.7pp-1,036.3%+34.8pp-1,071.2%+8.2pp-1,079.4%+43.6pp-1,123%-90.1pp
Returns
Return on assets-134.6%+28.4pp-163%-22.4pp-140.6%+11.2pp-151.8%+38.8pp-190.7%-33.7pp
Efficiency
Asset turnover0.2×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Liquidity
Current ratio1.1×-0.2×1.3×-0.6×1.9×+0.8×1.1×+0.4×0.8×-0.3×
Quick ratio1.1×-0.2×1.3×-0.6×1.9×+0.8×1.1×+0.4×0.7×-0.3×
Cash ratio0.9×-0.3×1.2×-0.6×1.8×+0.7×1.1×+0.4×0.7×-0.3×
Leverage
Debt-to-equity0.4×
Debt-to-assets0.0×0.0×0.0×0.1×0.0×0.1×0.0×
Interest coverage-2,463.4×-305×-2,158.3×-158×-2,000.2×+84.1×-2,084.3×-8.3×-2,076×-305×
Valuation
Market capitalization$204.13M+58.5%$142.9M+38.9%$102.91M-20.1%$128.75M-4.8%$135.22M+178%
Enterprise value$177.85M+78.0%$110.01M+90.8%$57.65M-42.3%$99.9M-11.2%$112.49M+290%
Price / sales39.8×+10.2×30.4×+7.0×23.4×-6.1×29.5×-2.9×32.4×+21.2×
Price / book51×+34.7×
EV / sales34.6×+11.7×23.4×+10.3×13.1×-9.8×22.9×-4.0×27×+20.3×
Earnings yield-22.1%+20.9pp-40.6%+11.2pp-51.8%-8.9pp-42.9%+2.8pp-45.7%+48.0pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Lucid Diagnostics's profit margins?
Lucid Diagnostics (LUCD) runs a -66.8% gross margin and a -959.6% operating margin, with a -876.7% net margin.
Where do Lucid Diagnostics's ratios come from?
Every ratio is computed from Lucid Diagnostics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.